Brief: Neurotech International Seeks Trading Halt
03/10/2023 23:13
Oct 4 (Reuters) - Neurotech International Ltd NTI.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF
PHASE I/II
CLINICAL TRIAL IN PAEDIATRIC PATIENTS WITH PANDAS/PANS
Source text for Eikon: ID:nASX5R5hWK
Further company coverage: NTI.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Neurotech International
See all newsBrief: Neurotech International Says Anthony Filippis Resigns As CEO, MD
Brief: Neurotech International Appoints Mark Davies As Executive Chairman
Brief: Neurotech International Receives Binding Commitments For Around A$4.50 Million In Placement At A$0.014 Per Share
Australia's Neurotech International slips to a month low on discounted placement
Brief: Neurotech International Requests Trading Halt